alexa Personalized Nanomedicine Takes Aim At Cancer Treatment
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Farooq A. Sheikh
ScientificTracks Abstracts: Transl Med
DOI: 10.4172/2161-1025.S1.008
Abstract
Each year, nearly 1.4 million Americans are diagnosed with cancer, another 600,000 die from it. The medicines used as treatments have clear limitations. Chemotherapy, radiation, and surgery-all big three treatments-All wreak havoc on healthy cells and tissues as well as cancerous ones. If there is a case to be made for personalized medicine, ?cancer is it?. Current literature strongly supports the need for a great scientific effort to be made in this field. Notably, the lack of identified molecular biomarkers that fully explain the heritability of complex traits, and the inability to pinpoint causative genetic effects in some complex tumors, making it a very difficult for target recognition and treatment. However, for developing safe and effective medicines to cancer that raised hopes, nanomedicine ?is not just one more tool, it is an entire field benefiting from the use of the modern cutting edge molecular tools. Remarkably, they are enabling academic researchers and oncologists to combine all advances, creating nano sized particles that contain drugs targeting specific cell surface receptors and other potent molecules designed to kill cancerous cells. Targeting the most appropriate patients might be a way of using newer medicines in the most effective manner essentially devoid of side effects. Scientific advances in the use of genetic information to estimate disease risk, assess prognosis, and manage patient care. By rigorous target validation, identifying risk factors, prognostic factors, and predictive factors, hope is that interventions can be tailored to maximize patient benefit and minimize toxicity, the primary goal of personalized nanomedicine. But, many outstanding questions remain.
Biography
Farooq A. Sheikh is working as a Professor, in the Avalon University School of Medicine, Willemstad, Curacao. In 2005, he completed his Ph.D. from the prestigious Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. After one year as a paid lecturer (Jaypee University of Information Technology, India), He obtained a post doctoral position in the Mayo Clinic, Rochester MN, USA. In 2008, He was an invited speaker in Experimental Biology San Diego, California. After two years in Mayo Clinic, He had another opportunity to work as a scientist in the Faculty of De Medicine, World Health Organization (WHO) collaborative center, CNRS, Marseille, France for two years. He has an experience of more than 12 years of research and teaching from various medical institutions of world repute.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords